Literature DB >> 11867977

Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

George J Shaw1, Edward C Jauch, Frank P Zemlan.   

Abstract

STUDY
OBJECTIVE: Intracranial injuries (ICI) are associated with high mortality and morbidity. Unfortunately, tools for diagnosis and risk stratification of ICIs are limited in the emergency department setting. We determine the relationship between the presence or absence of a detectable cleaved serum tau protein (tau(c)), ICI, and outcome at hospital discharge in adults with closed head injuries (CHI).
METHODS: This was a prospective pilot study of adult patients with CHI presenting to the ED of an urban Level I trauma center. Patients presenting within 10 hours of a CHI who underwent a head computed tomographic (CT) scan were eligible. A blood sample was collected at presentation and the tau(c) level was measured. Initial Glasgow Coma Scale scores and demographic information were recorded. A chart review was performed to determine outcome and final readings on the initial head CT scan.
RESULTS: Patients were dichotomized to 1 of 2 groups, those with an ICI (n=17) and those with an isolated skull fracture or no CT abnormality (NICI) (n=11). The 2 groups were similar in regard to demographic composition, mechanism of injury, and coexisting injuries. A tau(c) level of more than 0 was associated with an increased chance of an ICI on the initial head CT scan (odds ratio 11.25; 95% confidence interval [CI] 1.17 to 108.4) and a greater chance of poor outcome, defined as death while in hospital or transfer to a nursing home at hospital discharge (odds ratio 8.17; 95% CI 1.42 to 47).
CONCLUSION: A tau(c) level of more than 0 is associated with a greater chance of intracranial injury and poor outcome in patients with CHI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867977     DOI: 10.1067/mem.2002.121214

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  18 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 2.  The Glymphatic System: A Beginner's Guide.

Authors:  Nadia Aalling Jessen; Anne Sofie Finmann Munk; Iben Lundgaard; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2015-05-07       Impact factor: 3.996

Review 3.  Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion.

Authors:  Linda Papa; Michelle M Ramia; Damyan Edwards; Brian D Johnson; Semyon M Slobounov
Journal:  J Neurotrauma       Date:  2015-01-23       Impact factor: 5.269

4.  Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.

Authors:  Ming C Liu; Linnet Akinyi; Dancia Scharf; Jixiang Mo; Stephen F Larner; Uwe Muller; Monika W Oli; Wenrong Zheng; Firas Kobeissy; Linda Papa; Xi-Chun Lu; Jitendra R Dave; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Eur J Neurosci       Date:  2010-02       Impact factor: 3.386

Review 5.  Potential Blood-based Biomarkers for Concussion.

Authors:  Linda Papa
Journal:  Sports Med Arthrosc Rev       Date:  2016-09       Impact factor: 1.985

6.  Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors.

Authors:  Pelin Cengiz; Frank Zemlan; Jens C Eickhoff; Richard Ellenbogen; Jerry J Zimmerman
Journal:  Childs Nerv Syst       Date:  2015-04-22       Impact factor: 1.475

7.  Serologic markers of brain injury and cognitive function after cardiopulmonary bypass.

Authors:  Basel Ramlawi; James L Rudolph; Shigetoshi Mieno; Kamal Khabbaz; Neel R Sodha; Munir Boodhwani; Sue E Levkoff; Edward R Marcantonio; Frank W Sellke
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

8.  Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside.

Authors:  Zhiqun Zhang; Stefania Mondello; Firas Kobeissy; Richard Rubenstein; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Transl Stroke Res       Date:  2011-12-07       Impact factor: 6.829

9.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

10.  Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury.

Authors:  Marek Ma; Christopher J Lindsell; Clark M Rosenberry; George J Shaw; Frank P Zemlan
Journal:  Am J Emerg Med       Date:  2008-09       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.